BetterLife Pharma Inc. reported earnings results for the full year ended January 31, 2023. For the full year, the company reported net loss was CAD 9.37 million compared to CAD 12.16 million a year ago. Basic loss per share from continuing operations was CAD 0.1 compared to CAD 0.16 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0872 USD | +0.23% | -3.75% | +81.67% |
May. 14 | BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001 | CI |
May. 03 | BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+81.67% | 10.1M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- BETRF Stock
- News BetterLife Pharma Inc.
- BetterLife Pharma Inc. Reports Earnings Results for the Full Year Ended January 31, 2023